Immunotherapy is at the forefront of cancer care; however, most cancers evolve the ability to dodge the body’s defenses.
Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells – those that cause cancer and the ones that make it recurrent.
{iframe}http://medcitynews.com/2014/11/building-viruses-kill-cancer-cells-benevir-gets-2m-waiting-10m/{/iframe}